These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32316860)

  • 1. Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry.
    Hale PM; Ali AK; Buse JB; McCullen MK; Ross DS; Sabol ME; Tuttle RM; Stemhagen A
    Thyroid; 2020 Oct; 30(10):1397-1398. PubMed ID: 32316860
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
    Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinico-pathological and prognostic findings on 27 cases of medullary thyroid carcinoma.
    Gabsi A; El Amine El Hadj O; Goucha A; Said G; Laabidi B; Gamoudi A
    Tunis Med; 2017 Feb; 95(2):97-102. PubMed ID: 29424867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
    Erba PA; Maecke H; Mikolajczak R; Decristoforo C; Zaletel K; Maina-Nock T; Peitl PK; Garnuszek P; Froberg A; Goebel G; de Jong M; Jabrocka-Hybel A; Konijnenberg M; Virgolini I; Nock B; Lenda-Tracz W; Pawlak D; Rangger C; Trofimiuk-Müldner M; Sowa-Staszczak A; Tomaszuk M; von Guggenberg E; Scarpa L; Hubalewska-Dydejczyk A
    Pol Arch Intern Med; 2018 Dec; 128(12):791-795. PubMed ID: 30516761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of thyroid cancer in Spain].
    Galofré JC
    Endocrinol Nutr; 2010 Oct; 57(8):347-9. PubMed ID: 20801726
    [No Abstract]   [Full Text] [Related]  

  • 6. Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
    Santos JE; Kalk WJ; Freitas M; Marques Carreira I; Castelo Branco M
    BMC Res Notes; 2015 Jul; 8():284. PubMed ID: 26126625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program.
    Zhao Z; Yin XD; Zhang XH; Li ZW; Wang DW
    Sci Rep; 2020 Aug; 10(1):13310. PubMed ID: 32764626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
    Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of Medullary Thyroid Carcinoma from a proband].
    Morlán Herrador L; de Arriba A; Miguel G; Ferrera M; Labarta JI
    Arch Argent Pediatr; 2016 Dec; 114(6):e421-e424. PubMed ID: 27869424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer.
    Rowe CW; Bendinelli C; McGrath S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):340-3. PubMed ID: 27230389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary lesions of indolent course: reducing the overdiagnosis of indolent papillary thyroid cancer and unnecessary treatment.
    Brito JP; Davies L; Zeballos-Palacios C; Morris JC; Montori VM
    Future Oncol; 2014 Jan; 10(1):1-4. PubMed ID: 24328403
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymph node metastases in pediatric medullary thyroid carcinoma.
    Oliver JR; Patel KN; Chang CM; Baldwin CK; Brar PC; Morris LGT; Givi B
    Surgery; 2021 Sep; 170(3):736-742. PubMed ID: 33838880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal calcitonin amyloidosis in a patient with disseminated medullary thyroid carcinoma.
    Tan Y; Li DY; Ma TT; Xu R; Zhou FD; Wang SX; Zhao MH
    Amyloid; 2020 Sep; 27(3):213-214. PubMed ID: 32425063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroid carcinoma. Clinical strategy and therapeutic course].
    Baschieri L; Breccia M; De Negri F
    Minerva Med; 1986 Nov; 77(44):2121-6. PubMed ID: 3785729
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent medullary and papillary carcinoma of thyroid.
    Ateşpare A; Çalış AB; Çelik Ö; Yener N; Vural Ç
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(3):170-3. PubMed ID: 26050858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma.
    Pediatrics; 2018 Dec; 142(6):. PubMed ID: 30478244
    [No Abstract]   [Full Text] [Related]  

  • 19. Demographic, clinical, and genetic characteristics of patients with medullary thyroid cancer in the past 16 years in Castilla-La Mancha.
    Louhibi L; Marco A; Pinés PJ; Padillo JC; Gómez I; Valero MA; Alramadán M; Herranz S; Aguirre M; Hernández A
    Endocrinol Nutr; 2014 Oct; 61(8):398-403. PubMed ID: 24794695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview on the management of medullary thyroid carcinoma.
    Laglia G; Napolitano G; Di Felice G; Saccomandi M; Lio S; Monaco F
    J Nucl Biol Med (1991); 1991; 35(4):321-2. PubMed ID: 1823847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.